<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d265">
    <sentence id="DDI-DrugBank.d265.s0" text="Chlorthalidone may add to or potentiate the action of other antihypertensive drugs.">
        <entity id="DDI-DrugBank.d265.s0.e0" charOffset="0-13"
            type="drug" text="Chlorthalidone"/>
        <entity id="DDI-DrugBank.d265.s0.e1" charOffset="60-81"
            type="group" text="antihypertensive drugs"/>
        <pair id="DDI-DrugBank.d265.s0.p0" e1="DDI-DrugBank.d265.s0.e0"
            e2="DDI-DrugBank.d265.s0.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s1" text="Potentiation occurs with ganglionic peripheral adrenergic blocking drugs.">
        <entity id="DDI-DrugBank.d265.s1.e0" charOffset="25-71"
            type="group" text="ganglionic peripheral adrenergic blocking drugs"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s2" text="Medication such as digitalis may also influence serum electrolytes.">
        <entity id="DDI-DrugBank.d265.s2.e0" charOffset="19-27"
            type="group" text="digitalis"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s3" text="Warning signs, irrespective of cause, are: dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting."/>
    <sentence id="DDI-DrugBank.d265.s4" text="Insulin requirements in diabetic patients may be increased, decreased, or unchanged.">
        <entity id="DDI-DrugBank.d265.s4.e0" charOffset="0-6"
            type="drug" text="Insulin"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s5" text="Higher dosage of oral hypoglycemic agents may be required.">
        <entity id="DDI-DrugBank.d265.s5.e0" charOffset="22-40"
            type="group" text="hypoglycemic agents"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s6" text="Latent diabetes mellitus may become manifest during chlorthalidone administration.">
        <entity id="DDI-DrugBank.d265.s6.e0" charOffset="52-65"
            type="drug" text="chlorthalidone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s7" text="Chlorthalidone and related drugs may increase the responsiveness to tubocurarine.">
        <entity id="DDI-DrugBank.d265.s7.e0" charOffset="0-13"
            type="drug" text="Chlorthalidone"/>
        <entity id="DDI-DrugBank.d265.s7.e1" charOffset="68-79"
            type="drug" text="tubocurarine"/>
        <pair id="DDI-DrugBank.d265.s7.p0" e1="DDI-DrugBank.d265.s7.e0"
            e2="DDI-DrugBank.d265.s7.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s8" text="Chlorthalidone and related drugs may decrease arterial responsiveness to norepinephrine.">
        <entity id="DDI-DrugBank.d265.s8.e0" charOffset="0-13"
            type="drug" text="Chlorthalidone"/>
        <entity id="DDI-DrugBank.d265.s8.e1" charOffset="73-86"
            type="drug" text="norepinephrine"/>
        <pair id="DDI-DrugBank.d265.s8.p0" e1="DDI-DrugBank.d265.s8.e0"
            e2="DDI-DrugBank.d265.s8.e1" ddi="true" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d265.s9" text="This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use."/>
</document>
